Suppr超能文献

鞘内注射可乐定联合舒芬太尼用于分娩镇痛。

Intrathecal clonidine combined with sufentanil for labor analgesia.

作者信息

Gautier P E, De Kock M, Fanard L, Van Steenberge A, Hody J L

机构信息

Department of Anesthesiology, Clinique Ste. Anne-St. Remi, Brussels, Belgium.

出版信息

Anesthesiology. 1998 Mar;88(3):651-6. doi: 10.1097/00000542-199803000-00015.

Abstract

BACKGROUND

Intrathecal sufentanil provides rapid-onset and complete analgesia for the first stage of labor. The dose required to produce this effect can be associated with maternal respiratory depression, hypotension, nausea, or pruritus. Because clonidine potentiates the analgesic effects of opioids without increasing their side effects, the authors wanted to determine the efficacy of low doses of intrathecal clonidine (15 and 30 microg) combined with sufentanil.

METHODS

Ninety-eight parturient requesting labor analgesia were studied. In a combined spinal-epidural technique, patients were randomly assigned to receive one of the following intrathecal solutions: either 15 microg clonidine (n = 10); 30 microg clonidine (n = 10); 2.5 microg sufentanil (n = 13); 5 microg sufentanil (n = 13); 2.5 microg sufentanil and 15 microg clonidine (n = 13); 2.5 microg sufentanil and 30 microg clonidine (n = 13); 5 microg sufentanil and 15 microg clonidine (n = 13); or 5 microg sufentanil and 30 microg clonidine (n = 13). Visual analog scores for pain, blood pressure, heart rate, sensory levels, incidence of nausea and pruritus, and motor blockade, and maternal and cord blood concentrations of clonidine were recorded.

RESULTS

Patients receiving 30 microg intrathecal clonidine with 2.5 or 5 microg intrathecal sufentanil had significantly longer-lasting analgesia (145 +/- 36 and 145 +/- 43 min vs. 104 +/- 35 for those receiving 5 microg intrathecal sufentanil alone). Clonidine levels were undetectable in maternal serum.

CONCLUSIONS

Thirty micrograms of intrathecal clonidine combined with 2.5 or 5 microg intrathecal sufentanil significantly increased the duration of analgesia during the first stage of labor without adverse maternal or fetal effects.

摘要

背景

鞘内注射舒芬太尼可为第一产程提供起效迅速且完全的镇痛效果。产生这种效果所需的剂量可能会导致产妇呼吸抑制、低血压、恶心或瘙痒。由于可乐定可增强阿片类药物的镇痛效果而不增加其副作用,作者想要确定低剂量鞘内注射可乐定(15微克和30微克)联合舒芬太尼的疗效。

方法

对98名要求分娩镇痛的产妇进行研究。采用联合腰麻-硬膜外技术,将患者随机分配接受以下鞘内溶液之一:15微克可乐定(n = 10);30微克可乐定(n = 10);2.5微克舒芬太尼(n = 13);5微克舒芬太尼(n = 13);2.5微克舒芬太尼和15微克可乐定(n = 13);2.5微克舒芬太尼和30微克可乐定(n = 13);5微克舒芬太尼和15微克可乐定(n = 13);或5微克舒芬太尼和30微克可乐定(n = 13)。记录疼痛视觉模拟评分、血压、心率、感觉平面、恶心和瘙痒发生率、运动阻滞情况,以及产妇和脐血中可乐定的浓度。

结果

鞘内注射30微克可乐定联合2.5微克或5微克鞘内舒芬太尼的患者镇痛持续时间显著更长(分别为145±36分钟和145±43分钟,而单独接受5微克鞘内舒芬太尼的患者为104±35分钟)。产妇血清中未检测到可乐定水平。

结论

鞘内注射30微克可乐定联合2.5微克或5微克鞘内舒芬太尼可显著延长第一产程的镇痛时间,且对产妇和胎儿无不良影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验